RELX Plc logo

RELX Plc

RELX

NYSEIndustrialsSpecialty Business Services

Previous close

$35.91

+$0.53 · +1.50%

Aug 21, 4:00 PM ET

Pre-market

$35.79

−$0.12 · -0.33%

Aug 24, 6:15 AM ET

RELX company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

90

Deep Value

Momentum

34

Weakening

Sentiment

49

Mixed

Risk resilience

61

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.

Industry
Specialty Business Services
Sector
Industrials
Headquarters
GB
CEO
Erik Engstrom
Listed since
Oct 6, 1994
Employees
37,000

Market position

Day range

Current $35.91

52-week range

Current $35.91

Open
$35.495
Previous close
$35.38
Volume
2.12M
0.79× average
Average volume
2.67M
Average daily volume
Market cap
62.7B USD
Beta
0.26
Market reference 1
50-day average
$33.7358
+6.44% above average
200-day average
$35.7702
+0.39% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
62.22B GBP
P/E (TTM)
20.74×
P/B (TTM)
37.71×
P/S (TTM)
4.69×
EV / EBITDA
16.74×
Earnings yield
3.75%
Free cash flow yield
4.20%
Dividend yield
1.55%

Profitability & efficiency

Gross margin
62.65%
Operating margin
31.55%
Net margin
23.27%
Return on equity
87.43%
Return on assets
14.02%
Return on invested capital
21.79%

Financial health

Debt / equity
7.19×
Current ratio
0.49×
Altman Z-score
4.35
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends71%52%33%14%Gross margin, FY2021: 64.63%Gross margin, FY2022: 64.40%Gross margin, FY2023: 64.89%Gross margin, FY2024: 65.02%Gross margin, FY2025: 66.29%Operating margin, FY2021: 26.01%Operating margin, FY2022: 27.16%Operating margin, FY2023: 29.28%Operating margin, FY2024: 30.33%Operating margin, FY2025: 31.11%Net margin, FY2021: 20.31%Net margin, FY2022: 19.10%Net margin, FY2023: 19.44%Net margin, FY2024: 20.50%Net margin, FY2025: 21.53%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 64.63%. Gross margin FY2022 64.40%. Gross margin FY2023 64.89%. Gross margin FY2024 65.02%. Gross margin FY2025 66.29%. Operating margin FY2021 26.01%. Operating margin FY2022 27.16%. Operating margin FY2023 29.28%. Operating margin FY2024 30.33%. Operating margin FY2025 31.11%. Net margin FY2021 20.31%. Net margin FY2022 19.10%. Net margin FY2023 19.44%. Net margin FY2024 20.50%. Net margin FY2025 21.53%.

Income trends

Revenue

9.59B GBP+1.65%

Operating income

2.98B GBP+4.26%

Net income

2.07B GBP+6.77%
Income trends across reported periods10.4B GBP7.15B GBP3.91B GBP659.1M GBPRevenue, FY2021: 7.24B GBPRevenue, FY2022: 8.55B GBPRevenue, FY2023: 9.16B GBPRevenue, FY2024: 9.43B GBPRevenue, FY2025: 9.59B GBPOperating income, FY2021: 1.88B GBPOperating income, FY2022: 2.32B GBPOperating income, FY2023: 2.68B GBPOperating income, FY2024: 2.86B GBPOperating income, FY2025: 2.98B GBPNet income, FY2021: 1.47B GBPNet income, FY2022: 1.63B GBPNet income, FY2023: 1.78B GBPNet income, FY2024: 1.93B GBPNet income, FY2025: 2.07B GBPFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 7.24B GBP. Revenue FY2022 8.55B GBP. Revenue FY2023 9.16B GBP. Revenue FY2024 9.43B GBP. Revenue FY2025 9.59B GBP. Operating income FY2021 1.88B GBP. Operating income FY2022 2.32B GBP. Operating income FY2023 2.68B GBP. Operating income FY2024 2.86B GBP. Operating income FY2025 2.98B GBP. Net income FY2021 1.47B GBP. Net income FY2022 1.63B GBP. Net income FY2023 1.78B GBP. Net income FY2024 1.93B GBP. Net income FY2025 2.07B GBP.
Metric (GBP)FY2025FY2024FY2023FY2022FY2021
Revenue9.59B GBP9.43B GBP9.16B GBP8.55B GBP7.24B GBP
Cost of goods sold3.23B GBP3.3B GBP3.22B GBP3.05B GBP2.56B GBP
Gross profit6.36B GBP6.13B GBP5.95B GBP5.51B GBP4.68B GBP
Research and development352M GBP364M GBP330M GBP309M GBP295M GBP
Selling, general, and administrative3.37B GBP3.32B GBP3.31B GBP3.2B GBP2.83B GBP
Operating expenses3.33B GBP3.27B GBP3.26B GBP3.2B GBP2.83B GBP
Interest income11.74M GBP9M GBP7M GBP4M GBP8M GBP
Interest expense291.47M GBP281M GBP300M GBP205M GBP150M GBP
Depreciation and amortization735.52M GBP292M GBP717M GBP785M GBP724M GBP
Operating income2.98B GBP2.86B GBP2.68B GBP2.32B GBP1.88B GBP
Net income2.07B GBP1.93B GBP1.78B GBP1.63B GBP1.47B GBP

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
20%
2 beats, 7 misses, 1 met estimate
Average EPS surprise
-7.30%
10 comparable reports
Latest EPS result
0.91
Estimate 0.89 · Beat by 2.24%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates10.840.680.52Q2 '23MissQ3 '24MetQ4 '24MissQ1 '25MissQ3 '25BeatQ1 '26MissQ3 '26BeatQ1 '27Estimate
Q2 2023, reported Jun 30, 2023: actual 0.58, estimate 0.689, surprise -15.82%, Miss. Q3 2024, reported Jul 25, 2024: actual 0.766, estimate 0.766, surprise 0.00%, Met estimate. Q4 2024, reported Oct 24, 2024: actual 0.655, estimate 0.766, surprise -14.49%, Miss. Q1 2025, reported Feb 14, 2025: actual 0.644, estimate 0.796, surprise -19.10%, Miss. Q3 2025, reported Jul 24, 2025: actual 0.721, estimate 0.563, surprise +28.06%, Beat. Q1 2026, reported Feb 12, 2026: actual 0.794, estimate 0.851, surprise -6.70%, Miss. Q3 2026, reported Jul 23, 2026: actual 0.914, estimate 0.894, surprise +2.24%, Beat. Q1 2027, reported Feb 18, 2027: actual —, estimate 0.955, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates7.23B6.63B6.02B5.42BQ2 '23MissQ3 '24MissQ4 '24MissQ1 '25MissQ3 '25BeatQ1 '26MissQ3 '26MissQ1 '27Estimate
Q2 2023, reported Jun 30, 2023: actual 5.7B USD, estimate 5.71B USD, surprise -0.31%, Miss. Q3 2024, reported Jul 25, 2024: actual 5.98B USD, estimate 6.12B USD, surprise -2.34%, Miss. Q4 2024, reported Oct 24, 2024: actual 5.87B USD, estimate 6.12B USD, surprise -4.01%, Miss. Q1 2025, reported Feb 14, 2025: actual 6B USD, estimate 6.45B USD, surprise -7.03%, Miss. Q3 2025, reported Jul 24, 2025: actual 6.46B USD, estimate 6.45B USD, surprise +0.13%, Beat. Q1 2026, reported Feb 12, 2026: actual 6.62B USD, estimate 6.7B USD, surprise -1.23%, Miss. Q3 2026, reported Jul 23, 2026: actual 6.49B USD, estimate 6.54B USD, surprise -0.77%, Miss. Q1 2027, reported Feb 18, 2027: actual —, estimate 6.95B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$26.00

27.60% downside
Past 12 months12-month forecastHigh $28.00Average $26.00Low $24.00

Rating distribution

7 ratings
Strong buy00%
Buy571%
Hold229%
Sell00%
Strong sell00%

Recent analyst actions

3 institutions
CitigroupupgradeNeutralBuy
BarclaysupgradeEqual WeightOverweight
Goldman SachsupgradeNeutralBuy

RELX news

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$0.8664

2025 complete year+30.1% since 2021

2026 partial: $0.2785

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Aug 7, 2026

$0.2785

Semi-Annual

Record Aug 7, 2026 · Payment Sep 15, 2026

Dividend

Ex-dividend Aug 8, 2025

$0.2638

Semi-Annual

Record Aug 8, 2025 · Payment Sep 16, 2025

Dividend

Ex-dividend May 9, 2025

$0.6026

Semi-Annual

Record May 9, 2025 · Payment Jun 25, 2025

Dividend

Ex-dividend Aug 2, 2024

$0.2392

Semi-Annual

Record Aug 2, 2024 · Payment Sep 10, 2024

Dividend

Ex-dividend May 2, 2024

$0.534

Semi-Annual

Record May 3, 2024 · Payment Jun 18, 2024

Dividend

Ex-dividend Aug 3, 2023

$0.2118

Semi-Annual

Record Aug 4, 2023 · Payment Sep 12, 2023

RELX peers

ETFs holding RELX

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research RELX

research.disclaimer